Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Arm, Multi-center Study to Assess the Long-term Real-world Safety and Effectiveness of Nucala in EGPA Patients Who Have Already Used Nucala for at Least 96 Weeks in Japan

NCT04551989 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT04551989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04551989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Arm, Multi-center Study to Assess the Long-term Real-world Safety and Effectiveness of Nucala in EGPA Patients Who Have Already Used Nucala for at Least 96 Weeks in Japan
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
December 11, 2020
Completion date
April 27, 2023
Enrollment
118 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

churg-strauss syndrome, eosinophilic granulomatosis with polyangiitis